Kate Xiong

Founder at First Rice Capital

📍 Hong Kong🔄 Updated September 2026💼 2 investments📅 8 years investing🗓 Last invested Mar 2019
VC🌍 Hong Kong
2
Total investments
1
Early stage
0
Mid stage
1
Late stage
8y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Mar 2019
Mirakel Technologies is a Cambridge, MA based company that develops proprietary technologies in the area of cosmetics and hair-care. The mission of the company is to apply breakthrough science to provide innovative and disruptive solutions leading to life changing experiences for consumers.
Board Member/Investor
Jan 2018
Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body. Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases. Based in Cambridge, MA, Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and supported by seasoned business leaders.
early stageBiotechnology
Experience · 4 entries
All (4)
Investments (2)
Board (2)
2019
Board Member
Mar 2019
Mirakel Technologies is a Cambridge, MA based company that develops proprietary technologies in the area of cosmetics and hair-care. The mission of the company is to apply breakthrough science to provide innovative and disruptive solutions leading to life changing experiences for consumers.
2018
Board Member/Investor
Jan 2018
Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body. Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases. Based in Cambridge, MA, Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and supported by seasoned business leaders.
early stageBiotechnology
2007
China Equity Analyst
Jun 2007
Highbridge Capital Management is a global alternative investment firm offering relative value, credit and volatility focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles and co-investments
2004
Exective Director
Aug 2004
We aspire to be the world’s most exceptional financial institution, united by our shared values of partnership, client service, integrity, and excellence. Operating at the center of capital markets, we act as one firm, mobilizing our people, capital, and ideas to deliver superior results across our clients’ most complex challenges. For 157 years, Goldman Sachs has delivered world-class execution on a global scale across our leading Global Banking & Markets and Asset & Wealth Management businesses. Apprenticeship is central to our culture, with hands-on coaching and access to leaders who bring decades of experience and expertise. With office locations around the world, we offer a broad range of career opportunities to those who insist on excellence and thrive on performance. Find our Social Media Disclosures here: gs.com/social-media-disclosures